However, increasing evidence demonstrates that Hes1 is aberrantly expressed in many human malignancies Hes1 can serve as a potential prognostic biomarker for cancer and is expected to become a significant target in the field of cancer therapy. This evidence concerns the gene HES1 and cancer.